Cancer

First-in-class small molecule inhibitor designed with AI support shows promise against pancreatic cancer in preclinical studies

Rebecca Bromelkamp

August 5, 2026

JACKSONVILLE, Fla. — Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ-domain of GIPC1[...]

Model for rare cancer results instead in obesity

Mayo Clinic Staff

January 19, 2021

Science Saturday: All adrenal tumors should be investigated

Mayo Clinic Staff

January 16, 2021

Science Saturday: Seeing cancer, but not through a microscope

Marla Broadfoot, Ph.D.

October 24, 2020

Scientists Research New Ways to Tackle Brain Cancer

Mayo Clinic Staff

September 28, 2020

To Beat 1 of the Biggest Killers, Scientists Think Small

Mayo Clinic Staff

December 23, 2019

The Making of an Expert

Jon Holten

December 17, 2019

A Powerhouse of Cancer Research: A View from Florida

Mayo Clinic Staff

December 5, 2019

Science Saturday: Mimicking cancer, one model at a time

Mayo Clinic Staff

November 2, 2019

Science Saturday: Glioma Forecast? Excellent Chance for Better Weather says Researcher

Mayo Clinic Staff

October 26, 2019

Pancreatitis: New Therapy Shows Promise in Mice

Mayo Clinic Staff

October 7, 2019

Mayo Clinic Cancer Center Renews NCI Research Funding

Mayo Clinic Staff

September 11, 2019

Science Saturday: An anti-cancer idea goes viral

Mayo Clinic Staff

August 17, 2019

Explore more topics

Sign up

For Journalists Only Sign up for a Journalist Pass

Mayo Clinic Connect

An online patient support community

Health Topics

Research

Cancer

Explore more topics

Sign up

Mayo Clinic Connect